GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (FRA:RMN) » Definitions » Beginning Cash Position

MediciNova (FRA:RMN) Beginning Cash Position : €43.79 Mil (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is MediciNova Beginning Cash Position?

MediciNova's Beginning Cash Position for the quarter that ended in Jun. 2024 was €43.79 Mil.

MediciNova's quarterly Beginning Cash Position declined from Dec. 2023 (€47.23 Mil) to Mar. 2024 (€46.92 Mil) and declined from Mar. 2024 (€46.92 Mil) to Jun. 2024 (€43.79 Mil).

MediciNova's annual Beginning Cash Position increased from Dec. 2021 (€53.13 Mil) to Dec. 2022 (€67.43 Mil) but then declined from Dec. 2022 (€67.43 Mil) to Dec. 2023 (€16.97 Mil).


MediciNova Beginning Cash Position Historical Data

The historical data trend for MediciNova's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediciNova Beginning Cash Position Chart

MediciNova Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.08 52.44 53.13 67.43 16.97

MediciNova Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.01 49.55 47.23 46.92 43.79

MediciNova Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


MediciNova Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of MediciNova's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


MediciNova Business Description

Traded in Other Exchanges
Address
4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

MediciNova Headlines

No Headlines